Krónikus vesebetegség: vizsgálatok itt: Kanada
43 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Edmonton, Etobicoke, Halifax, Laval, London, Montreal, Oshawa, Québec, Saint John, Sarnia, Surrey, Toronto, Vancouver, Waterloo, Winnipeg
- Életkor
- 18 év and over
- People
- 5000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - 3. fázisTaking peopleA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Brampton, Cambridge, Chicoutimi, Hamilton, Laval, Moncton, Montreal, Québec, Sarnia, Scarborough, Surrey, Trois-Rivières, Waterloo, Winchester, Windsor, Winnipeg
- Életkor
- 50 év and over
- People
- 7140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - No phaseCsak meghívásosAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
- Where
- Calgary, Edmonton, Hamilton, Montreal, Toronto, Vancouver
- Életkor
- 0 Minutes to 2 hét
- People
- 8000 worldwide
- Run by
- Indiana University
See details and how to joinNCT06823115 - No phaseTaking peopleSensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
- Where
- Toronto, Winnipeg
- Életkor
- 21 év and over
- People
- 125 worldwide
- Run by
- Bodyport Inc.
See details and how to joinNCT07059962 - No phaseTaking peopleVisceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD
- Where
- Edmonton
- Életkor
- 18 év and over
- People
- 52
- Run by
- University of Alberta
See details and how to joinNCT07187830 - 3. fázisTaking peopleA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Where
- Oshawa
- Életkor
- 18 év to 100 év
- People
- 540 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00 - 4. fázisNot yet taking people in KanadaPatient-centred Intervention With Virtual Support for Obesity and Kidney Transplant Access
- Where
- London
- Életkor
- 18 év and over
- People
- 880
- Run by
- Kristin Clemens
See details and how to joinNCT07858331 - No phaseTaking peopleTelemonitoring of Hypertensive Patients With Chronic Kidney Disease
- Where
- Edmonton
- Életkor
- 18 év and over
- People
- 146
- Run by
- University of Alberta
See details and how to joinNCT04098354 - 3. fázisTaking peopleA Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
- Where
- Calgary, Montreal
- Életkor
- 1 év to 18 év
- People
- 100 worldwide
- Run by
- Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00 - No phaseTaking peopleDIALysis With EXpanded Solute Removal
- Where
- London, Orillia, Ottawa
- Életkor
- 45 év and over
- People
- 4800
- Run by
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
See details and how to joinNCT06660277 - 3. fázisTaking peopleA Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
- Where
- Brampton, Calgary, Edmonton, Greater Sudbury, Halifax, London, Mississauga, Montreal, Oakville, Québec, Toronto, Waterloo, Winnipeg
- Életkor
- 18 év to 99 év
- People
- 2800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00 - 2/3. fázisTaking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Edmonton, Halifax, Hamilton, Kingston, London, Longueuil, Montreal, Oshawa, Ottawa, Sherbrooke, Toronto, Vancouver, Winnipeg
- Életkor
- 18 év and over
- People
- 3110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - No phaseTaking peopleCKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients
- Where
- London, Scarborough Village, Winnipeg
- Életkor
- 18 év and over
- People
- 340
- Run by
- University of Manitoba
See details and how to joinNCT05726526 - 3. fázisTaking peopleA Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Where
- Calgary, Edmonton, London, Montreal, Saint John, Scarborough Village, Sherbrooke, Toronto, Vancouver, Waterloo, Winnipeg
- Életkor
- 18 év and over
- People
- 7000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00 - No phaseTaking peopleGoal-Directed Therapy to Reduce Kidney and Cardiovascular Risk in Diabetic Kidney Disease (GOLD-STANDARD)
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 100
- Run by
- Sunnybrook Health Sciences Centre
See details and how to joinNCT07434791 - No phaseTaking peoplePragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
- Where
- Calgary, Edmonton, Halifax, Kingston, London, Longueuil, Montreal, North York, Oakville, Orillia, Oshawa, Ottawa, Québec, Red Deer, Regina, Richmond Hill, Scarborough Village, Sherbrooke, Toronto, Vancouver, Winnipeg
- Életkor
- 18 év and over
- People
- 3600 worldwide
- Run by
- The University of Queensland
See details and how to joinNCT03573089 - No phaseNot yet taking people in KanadaFinerenone for AKI: a Multicenter, Randomized, Placebo-Controlled Feasibility Pilot Trial
- Where
- Montreal
- Életkor
- 18 év and over
- People
- 72
- Run by
- Jean-Maxime Côté
See details and how to joinNCT07775482 - No phaseNot yet taking people in KanadaLiberalizing Potassium Restrictions in Patients Receiving Hemodialysis
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 148
- Run by
- University of Ontario Institute of Technology
See details and how to joinNCT07772856 - No phaseNot yet taking people in KanadaDesigning and Implementing a Safety Net Surveillance Program for High Risk CKD
- Where
- Winnipeg
- Életkor
- 18 év and over
- People
- 972
- Run by
- University of Manitoba
See details and how to joinNCT07724288 - No phaseNot yet taking people in KanadaDialysis Less Frequently in the Elderly
- Where
- Halifax, Kingston, Montreal, Québec, St. John's, Vancouver
- Életkor
- 70 év and over
- People
- 210
- Run by
- Queen's University
See details and how to joinNCT07738731 - 4. fázisTaking peopleObesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2
- Where
- London
- Életkor
- 18 év and over
- People
- 60
- Run by
- Western University, Canada
See details and how to joinNCT06396416 - 4. fázisTaking peopleGlucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 100
- Run by
- Unity Health Toronto
See details and how to joinNCT07017270 - 2. fázisTaking peopleTrial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- University of Washington
See details and how to joinNCT05822609 - 3. fázisTaking peopleBleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial
- Where
- London, Montreal
- Életkor
- 18 év and over
- People
- 100
- Run by
- Hamilton Health Sciences Corporation
See details and how to joinNCT06337838 - No phaseTaking peopleFeasibility and Pilot Testing of "My Heart and CKD" Online Shared Decision Aid
- Where
- Calgary, Edmonton
- Életkor
- 18 év and over
- People
- 220
- Run by
- University of Calgary
See details and how to joinNCT06920927